FindTrial
Sign In

Research on CSF biomarker and abnormal PSG in Dementia with Lewy bodies

Research on CSF biomarker and abnormal PSG in Dementia with Lewy bodies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-10000857
Enrollment
Unknown
Registered
2010-05-02
Start date
2010-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia of Lewy body

Interventions

Gold Standard:
Index test:

Sponsors

Guangzhou Psychiatric Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Meet the criteria establshed by the Members of the Consortium on DLB (published in Neurology 2005) for "possible" or "probable" Dementia with Lewy bodies.

Exclusion criteria

Exclusion criteria: 1. Other forms of dementia (and by the history of \ symptoms \ signs \ image studies confirmed); 2. A variety of physical and neurological diseases, such as delirium; 3. Depression or other disease can lead to cognitive decline.

Design outcomes

Primary

MeasureTime frame
CSF t-tau protein, phosphorylated tau protein, aBeta-ox, alpha-synuclein levels, EEG polysomnography (PSG);—

Countries

China

Contacts

Public ContactYuping Ning
ningyuping2005@hotmail.com+86 13922214239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026